New veradigm leadership provides outlook on business and strategy, and refreshed financial estimates for fiscal 2023

Chicago--(business wire)-- #healthit--the new leadership team at veradigm inc. (nasdaq: mdrx), a leading provider of healthcare data and technology solutions, has provided refreshed estimated, unaudited ranges of financial information for fiscal 2023. dr. shih-yin ho, interim ceo, and lee westerfield, interim cfo, will discuss veradigm's mission, business and operations, and innovation strategy, as well as its estimated financial information for fiscal 2023, at the j.p. morgan healthcare conference on wedn.
MDRX Ratings Summary
MDRX Quant Ranking